Literature DB >> 27321895

Advances in the management of conjunctival melanoma.

Gargi K Vora1, Hakan Demirci2, Brian Marr3, Prithvi Mruthyunjaya4.   

Abstract

Malignant melanoma of the conjunctiva is a rare but serious condition. Over the last several years, there have been important advances in the classification, diagnosis, and treatment of this condition. Recent cytogenetic and immunohistochemical studies are increasing understanding of its tumorigenesis. Diagnosis, although still made via histopathology, has been aided with imaging techniques such as ultrasound biomicroscopy and anterior segment optical coherence tomography. Primary treatment consists of surgical excision. But adjuvant treatments with cryotherapy, topical chemotherapy, and radiation therapy have shown increased success. Sentinel lymph node biopsy has shown early promise of detecting micro-metastasis. Long term follow-up of patients with conjunctival melanoma with systemic surveillance is necessary to detect recurrences and metastases. Published by Elsevier Inc.

Entities:  

Keywords:  conjunctival melanoma; malignant melanoma of the conjunctiva

Mesh:

Year:  2016        PMID: 27321895      PMCID: PMC5353981          DOI: 10.1016/j.survophthal.2016.06.001

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  158 in total

1.  Corneal melanoma: report of three cases.

Authors:  Ömür Uçakhan-Gündüz; Kaan Gündüz; Melisa Z Karsloğlu; Aylin Okçu-Heper; Ayfer Kanpolat
Journal:  Eye Contact Lens       Date:  2012-09       Impact factor: 2.018

2.  Pigmented conjunctival squamous cell carcinoma simulating a conjunctival melanoma.

Authors:  J A Shields; C L Shields; R C Eagle; A D Singh; H Demirci; M A Wolf
Journal:  Am J Ophthalmol       Date:  2001-07       Impact factor: 5.258

3.  Impression cytology of conjunctival melanosis and melanoma.

Authors:  A D Paridaens; A C McCartney; O M Curling; C J Lyons; J L Hungerford
Journal:  Br J Ophthalmol       Date:  1992-04       Impact factor: 4.638

4.  Regional lymph node assessment for conjunctival melanoma: sentinel lymph node biopsy and positron emission tomography.

Authors:  Bita Esmaeli
Journal:  Br J Ophthalmol       Date:  2008-04       Impact factor: 4.638

Review 5.  Conjunctival melanoma.

Authors:  F A Jakobiec
Journal:  Arch Ophthalmol       Date:  1980-08

6.  Long-term follow-up of patients with conjunctival melanoma.

Authors:  Cornelia Werschnik; Peter K Lommatzsch
Journal:  Am J Clin Oncol       Date:  2002-06       Impact factor: 2.339

7.  Clinical mapping of conjunctival melanomas.

Authors:  B Damato; S E Coupland
Journal:  Br J Ophthalmol       Date:  2008-07-31       Impact factor: 4.638

8.  Malignant melanoma of the conjunctiva.

Authors:  R Folberg; I W McLean; L E Zimmerman
Journal:  Hum Pathol       Date:  1985-02       Impact factor: 3.466

9.  Topical treatment options for conjunctival neoplasms.

Authors:  Jonathan W Kim; David H Abramson
Journal:  Clin Ophthalmol       Date:  2008-09

10.  Whole-body 18 FDG PET/CT imaging for lymph node and metastatic staging of conjunctival melanoma.

Authors:  M Kurli; K Chin; P T Finger
Journal:  Br J Ophthalmol       Date:  2008-04       Impact factor: 4.638

View more
  23 in total

1.  [Conjunctival malignancies].

Authors:  Claudia Auw-Hädrich; Thomas Reinhard
Journal:  Ophthalmologe       Date:  2019-10       Impact factor: 1.059

2.  Adjunctive Treatment with Interferon Alpha 2b in Conjunctival Melanoma.

Authors:  Valentín Huerva; Pau Cid-Bertomeu; Ramón Espinet; Luisa M Canto
Journal:  Ocul Oncol Pathol       Date:  2022-01-27

3.  Conjunctival melanoma.

Authors:  Marilda Aparecida Milanez Morgado de Abreu; Jéssica Priscila Tozo; Amanda Kloster Wagner
Journal:  An Bras Dermatol       Date:  2018 Nov/Dec       Impact factor: 1.896

4.  Clinical Update on Checkpoint Inhibitor Therapy for Conjunctival and Eyelid Melanoma.

Authors:  Jonathan E Lu; Jessica R Chang; Jesse L Berry; Gino K In; Sandy Zhang-Nunes
Journal:  Int Ophthalmol Clin       Date:  2020

5.  Incidence and Survival of Patients With Conjunctival Melanoma in Europe.

Authors:  Gianni Virgili; Mariacristina Parravano; Gemma Gatta; Riccardo Capocaccia; Cinzia Mazzini; Sandra Mallone; Laura Botta
Journal:  JAMA Ophthalmol       Date:  2020-06-01       Impact factor: 7.389

Review 6.  Conjunctival Melanoma in Childhood and Adolescence: A Systematic Review.

Authors:  Ben W R Balzer; Svetlana Cherepanoff; Anthony M Joshua; Michael Giblin; Robert Max Conway; Antoinette C Anazodo
Journal:  Ocul Oncol Pathol       Date:  2019-04-10

7.  Annulus-shaped I-125 plaque brachytherapy for conjunctival melanoma.

Authors:  Sean T Berkowitz; Anderson L Brock; Melvin A Astrahan; David A Reichstein
Journal:  Am J Ophthalmol Case Rep       Date:  2022-04-18

8.  Immune Checkpoint Inhibitor Therapy as an Eye-Preserving Treatment for Locally Advanced Conjunctival Melanoma.

Authors:  Bennett Yau-Bun Hong; Joshua R Ford; Isabella C Glitza; Carlos A Torres Cabala; Michael Tetzlaff; Victor G Prieto; Richard Parker; Claire Daniel; Bita Esmaeli
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2021 Jan-Feb 01       Impact factor: 2.011

9.  Checkpoint inhibition immunotherapy for advanced local and systemic conjunctival melanoma: a clinical case series.

Authors:  Paul T Finger; Anna C Pavlick
Journal:  J Immunother Cancer       Date:  2019-03-25       Impact factor: 13.751

10.  Image Analysis of 3D Conjunctival Melanoma Cell Cultures Following Electrochemotherapy.

Authors:  Miltiadis Fiorentzis; Periklis Katopodis; Helen Kalirai; Berthold Seitz; Arne Viestenz; Sarah E Coupland
Journal:  Biomedicines       Date:  2020-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.